Nexentis Technologies Inc.
NXTS · XNASCIK 1789192fmd_1BKPPEG3601550XYHH271Z2BRQManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Jun 30, 2026, 31 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – |
| Net interest income | – | – | – | – | (0) | (0) | (0) | 0 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – |
| Provision for credit losses | (0) | 0 | 0 | 0 | – | – | – | – |
| Realized investment gains (losses) | – | – | – | – | – | (1) | (1) | 0 |
| Research and development | 0 | 1 | 0 | 1 | 1 | 2 | 0 | 0 |
| Selling, general and administrative | 0 | 1 | 1 | 4 | 5 | 6 | 4 | – |
| Total operating expenses | – | – | – | – | – | 3 | – | – |
| Operating income | (1) | (2) | (1) | (5) | (6) | (8) | (3) | (4) |
| Interest expense | – | 0 | 0 | 0 | – | – | 0 | – |
| Other non-operating income (expense) | 0 | (0) | (0) | – | – | – | 0 | 2 |
| Income before taxes | – | – | – | – | – | – | (4) | (4) |
| Income tax expense | – | – | – | – | – | – | – | (0) |
| Net income from continuing operations | – | – | – | – | – | – | (4) | (4) |
| Net income | (0) | (2) | (2) | (5) | (6) | (7) | (5) | (4) |